Hi Everyone! Thank you so much for all these heart-wrenching stories that are being shared by you all. Apologies that I haven’t responded sooner, but have been so busy! Some good news though! My PR team look as if they have secured some time on 2 major shows to discuss Essure. However, what they have

Despite Essure being released into the UK market for a short time, according to a recent article posted in the UK newspaper, The Daily Mail, issues arising from its use are starting to already appear in forums dedicated to women’s health issues. Read the article here

Hi everyone, Dan here! Just want to let you know that Erin has been incredibly busy over the last few months, both with the birth of her grand-daughter, Grace and a number of major environmental crisis as well. However, Erin intends to update everyone next week on some developments that she and her PR team

The issue of “pre-emption” is being keenly pursued by the American Association for Justice (AAJ) who are watching closely the US Supreme Court in the matter of Mutual v Bartlett. Karen’s story can be seen via this website ABC also did a feature here

Angie has just sent across this. It is definitely worth a read! Thanks Angie!

In October last year a petition was brought before the Supreme Court to review a decision which was made by the United States Court of Appeals (4th Circuit) in the matter of Walker v. Medtronic et al., The ruling made was in relation to the 1976 Medical Device Amendments to the Federal Food, Drug and

This is Penny’s Story, told courageously in her own words. Thanks Penny for sharing! Erin

Angie has done so much work campaigning against Essure and of course, bringing a community of women to rally together. In this audio interview, recorded in the last few days, Erin has the privilege of talking with Angie and maps out a strategy for all those who have suffered because of Essure. Listen below

This action is a product liability/medical malpractice litigation in which the plaintiff, Mrs. Riolo, claims personal injury by co-defendant medical providers and/or Conceptus’ product, the Essure System, a permanent contraception device. Plaintiffs’ claims against Conceptus are based upon theories of common law negligence (third cause of action), breach of warranty (fourth cause of action), strict